Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors

Steffi E M van De Ven, Lauranne A A P Derikx, Iris D Nagtegaal, Carla M van Herpen, Robert P Takes, Willem J G Melchers, Marieke Pierik, Tim van den Heuvel, Rob H A Verhoeven, Frank Hoentjen, L H C Nissen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1060-1067
Number of pages8
JournalInflammatory Bowel Diseases
Volume26
Issue number7
Early online date27 Sep 2019
DOIs
Publication statusPublished - Jul 2020

Keywords

  • inflammatory bowel diseases
  • head and neck cancer
  • laryngeal carcinoma
  • immunosuppressive therapy
  • SQUAMOUS-CELL CARCINOMA
  • LIVER-TRANSPLANTATION
  • COLORECTAL-CANCER
  • CROHNS-DISEASE
  • ULCERATIVE-COLITIS
  • NECK-CANCER
  • NATIONWIDE
  • NEOPLASIA
  • HEAD
  • MALIGNANCY

Cite this

van De Ven, S. E. M., Derikx, L. A. A. P., Nagtegaal, I. D., van Herpen, C. M., Takes, R. P., Melchers, W. J. G., Pierik, M., van den Heuvel, T., Verhoeven, R. H. A., Hoentjen, F., & Nissen, L. H. C. (2020). Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors. Inflammatory Bowel Diseases, 26(7), 1060-1067. https://doi.org/10.1093/ibd/izz210